Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
Figure 8
Ophthalmologic images of ipilimumab-associated uveitis in both eyes. (a, b) At the time of presentation, with irregular pupils caused by iris adhesions to the lens; (c, d) the same patient after 4 days of topical corticosteroid therapy [15]; reproduced with permission from Attia et al. 2005 [15].
